Figure 1. Relative abundance of clonal complexes of Campylobacter spp. detected in Oxfordshire, United Kingdom, during a 1-year study compared with clonal complexes detected in 3 other studies of human Campylobacter spp. infections in northwestern England (7), New South Wales, Australia (8), and Curaçao (9).
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.